A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2006
10/25/2006	CN1850204A Medicine composition for resisting exogenous cold and high fever, and its preparing method
10/25/2006	CN1850194A Patent Chinese medicinal tablet for treating exogenous cold and preparing technology
10/25/2006	CN1850192A Medicine composition for treating cerebral embolism sequela and rheumatoid arthritis and preparing method
10/25/2006	CN1850178A Method for preparing aconturm fischeri mankshood
10/25/2006	CN1850175A Method for preparing Radix-paeoniae-rubra formula granules
10/25/2006	CN1850161A Medicine composition for treating pain and preparing method therefor
10/25/2006	CN1850159A Navel plastering piece for treating dysmenorrhea and preparing method
10/25/2006	CN1850158A Tanshinoue dropping pills and preparing method
10/25/2006	CN1850154A Liquid capsule of Radix seu Herba Phlomis Rotatae and preparing method
10/25/2006	CN1850132A Herba thesii granules and preparing method therefor
10/25/2006	CN1850115A Method for preparing bear's gall dropping pills
10/25/2006	CN1850081A Use of 5-(3-aminobenzene)methyl nicotinate and its ahalogue as PI3K enzyme inhibitor
10/25/2006	CN1850077A Lappaconitine hydrobromide dispersible tablet and its preparing method
10/25/2006	CN1850070A Quercetin solid liposome nano particle preparation and its preparing method
10/25/2006	CN1850036A Slow-release preparation containing quinolones antibiotics
10/25/2006	CN1281613C Chinese medicine gelsmium elegans total alkaloid for anticancer and analgesia, and medicinal composition containing it and preparing method thereof
10/25/2006	CN1281608C New azo-indolyl derivatives
10/25/2006	CN1281604C Substituted pyrazole compounds
10/25/2006	CN1281603C Aminopyrrole compounds as antiinflammatory agents
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006	CN1281589C Preparation of 1-(6-methylpyridin-3-yl)-2-(4-methylsulfonyl-phenyl)ethanon
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/25/2006	CN1281259C Leadless plaster medium for Chinese medicine and preparing method
10/25/2006	CN1281254C Injection for curing rheumatism and rheumatoid and preparation process thereof
10/25/2006	CN1281250C Prepared Chinese external medicine for reducing swelling and ease pain
10/25/2006	CN1281246C Traditional Chinese medicine extract with anti-inflammatory action and promoting blood circulation function, and its preparation method
10/25/2006	CN1281218C Preparation method of clam meat extract
10/25/2006	CN1281212C General saponin of stem and leaf of American ginseng in Application of preparing medication for treating mycoarditis
10/24/2006	US7126027 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125868 Thienothiazine compound having anti-inflammatory and analgesic properties and method of making and using the same
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2261848C Cell adhesion inhibitors
10/24/2006	CA2252717C Colchicine-skeleton compounds, their use as medicaments and compositions containing them
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006	CA2195663C Dihydrobenzofuranes
10/19/2006	WO2006110917A2 Spiro-oxindole compounds and their uses as therapeutic agents
10/19/2006	WO2006110814A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
10/19/2006	WO2006110683A1 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
10/19/2006	WO2006110654A1 Spiroheterocyclic compounds and their uses as therapeutic agents
10/19/2006	WO2006110577A2 Use of fril proteins for reducing the production of pro-inflammatory cytokines
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006108712A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics
10/19/2006	WO2006108711A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
10/19/2006	WO2006108572A2 Novel crystalline pharmaceutical product
10/19/2006	WO2006108212A1 Anti-inflammatory modalities
10/19/2006	WO2006068932A3 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
10/19/2006	WO2006064336A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
10/19/2006	WO2006050006A3 ((1h-indazol-3-yl)methyl) phenols and (hydroxyphenyl)(1h-indazol-3-yl) methanones as ligands of the estrogen receptor
10/19/2006	US20060235061 Methods of using benzothiophenone derivatives to treat cancer or inflammation
10/19/2006	US20060235057 Phenyl compounds
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235033 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060235019 Substituted quinazolinone compounds
10/19/2006	US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma
10/19/2006	US20060235002 Novel physiologically active substance
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234990 Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
10/19/2006	US20060234980 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
10/19/2006	US20060234955 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
10/19/2006	US20060234937 Modulation of angiogenesis
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234919 Use
10/19/2006	US20060234909 Compositions and methods for increasing drug efficiency
10/19/2006	US20060233890 Method for treating a mammal by administration of a compound having the ability to release CO
10/19/2006	US20060233885 Analgesic agent for newborn or fetal subjects
10/19/2006	US20060233877 Betaine compositions
10/19/2006	US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis
10/19/2006	US20060233800 Biological products
10/19/2006	US20060233796 Method of modulating memory effector T-cells and compositions
10/19/2006	US20060233719 Delivery of antidepressants through an inhalation route
10/19/2006	US20060233706 Marked peptides having affinity for a phospholipid and uses
10/19/2006	DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds
10/19/2006	DE102005018024A1 New benzazepine stereoisomeric compounds useful as glucocorticoid receptor inhibitors to treat e.g. inflammatory diseases, atopic dermatitis, tumors and eye diseases
10/19/2006	DE102005017316A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories

1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 1272